Abstract Details Title Preclinical Efficacy and Phase I Clinical Testing of ATX-MS1467, an Antigen-Specific Immunotherapy for Multiple Sclerosis Topic Multiple Sclerosis Presentation(s) (-) Poster/Presentation Number 189 Objective Background Design/Methods Results Conclusions Authors/Disclosures David Wraith PRESENTER No disclosure on file Dimitri Guala No disclosure on file